Form 4: CalciMedica Executive Receives Stock Grant
Insider Transaction (Form 4)
Kenneth A. Stauderman, Chief Scientific Officer of CalciMedica, Inc., received 180,000 shares of common stock on September 24, 2026.
Summary
- Grant/award: acquired 180,000 Employee Stock Option (Right to Buy) on September 24, 2026; holds 180,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kenneth A. Stauderman — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-24 | Grant/award | Employee Stock Option (Right to Buy) | 180,000 | — | — | 180,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-24 | Grant/award (180,000 shares) |
Keywords
insider transaction, Form 4, CALC, CalciMedica, Inc., neutral, Kenneth A. Stauderman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.